Article Versions Notes

Irelli A, Chiatamone Ranieri S, Di Giacomo D, Malatesta S, Patruno LV, Tessitore A, Alesse E, Cannita K. Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy. Cancers. 2023; 15(6):1727. https://doi.org/10.3390/cancers15061727

Irelli, Azzurra, Sofia Chiatamone Ranieri, Daniela Di Giacomo, Sara Malatesta, Leonardo Valerio Patruno, Alessandra Tessitore, Edoardo Alesse, and Katia Cannita. 2023. "Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy" Cancers 15, no. 6: 1727. https://doi.org/10.3390/cancers15061727

Irelli, A., Chiatamone Ranieri, S., Di Giacomo, D., Malatesta, S., Patruno, L. V., Tessitore, A., Alesse, E., & Cannita, K. (2023). Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy. Cancers, 15(6), 1727. https://doi.org/10.3390/cancers15061727